NAMS
NewAmsterdam Pharma Company N.V.
23.80$
+1.0%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
NewAmsterdam Pharma Company N.V. (NAMS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -148 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -7.3 | -30 | 11 | -141 | -159 | -148 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | |
| 0.0 | 1.2 | 4.1 | 25 | 34 | 59 | |
| 0.3 | -0.4 | – | – | – | – | |
| -0.6 | 4.5 | 10 | 5.9 | -33 | -7.9 | |
| 0.0 | 0.0 | 0.2 | 0.0 | 0.7 | 0.2 | |
| 0.0 | 0.0 | -0.2 | 0.0 | -63 | -175 | |
| 11 | 0.0 | 0.7 | 0.0 | 0.0 | – | |
| 14 | 85 | 392 | 8.9 | 660 | 30 | |
| 6.6 | 50 | 408 | -127 | 431 | -280 | |
| -7.4 | -30 | 10 | -141 | -159 | -148 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.